Plant ID: NPO1034
Plant Latin Name: Ophiorrhiza liukiuensis
Taxonomy Genus: Ophiorrhiza
Taxonomy Family: Rubiaceae
NCBI TaxonomyDB:
489897
Plant-of-the-World-Online:
n.a.
China
NPSR1; | |
CA7; CA12; CA9; | |
NR1H4; | |
ALDH1A1; GFER; HSD17B10; AKR1B10; AKR1B1; | |
CASP7; CASP1; | |
NFKB1; | |
MAPT; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cysteine protease | CASP7 | Caspase-7 | P55210 | CHEMBL3468 |
Cysteine protease | CASP1 | Caspase-1 | P29466 | CHEMBL4801 |
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Cytochrome P450 family 2 | CYP2D6 | Cytochrome P450 2D6 | P10635 | CHEMBL289 |
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Enzyme_unclassified | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P00352 | CHEMBL3577 |
Enzyme_unclassified | GFER | FAD-linked sulfhydryl oxidase ALR | P55789 | CHEMBL1741189 |
Enzyme_unclassified | HSD17B10 | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Q99714 | CHEMBL4159 |
Enzyme_unclassified | AKR1B10 | Aldo-keto reductase family 1 member B10 | O60218 | CHEMBL5983 |
Enzyme_unclassified | AKR1B1 | Aldose reductase | P15121 | CHEMBL1900 |
Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Lyase | CA9 | Carbonic anhydrase IX | Q16790 | CHEMBL3594 |
Nuclear hormone receptor subfamily 1 group H | NR1H4 | Bile acid receptor FXR | Q96RI1 | CHEMBL2047 |
Peptide receptor (family A GPCR) | NPSR1 | Neuropeptide S receptor | Q6W5P4 | CHEMBL5162 |
Transcription Factor | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | P19838 | CHEMBL3251 |
Unclassified | MAPT | Microtubule-associated protein tau | P10636 | CHEMBL1293224 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 1.131E-08 | 1.458E-04 | CYP1A2, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0008202; steroid metabolic process | 4.526E-08 | 1.971E-04 | AKR1B1, AKR1B10, CYP1A2, CYP2D6, CYP3A4, NR1H4 |
BP | GO:0008152; metabolic process | GO:0070989; oxidative demethylation | 1.240E-07 | 2.999E-04 | CYP1A2, CYP2D6, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 2.559E-07 | 5.573E-04 | CA12, CA7, CA9 |
MF | GO:0003824; catalytic activity | GO:0070330; aromatase activity | 9.919E-07 | 1.800E-03 | CYP1A2, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0009822; alkaloid catabolic process | 2.186E-06 | 3.400E-03 | CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0017144; drug metabolic process | 3.882E-06 | 5.008E-03 | AKR1B1, AKR1B10, ALDH1A1, CYP1A2, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 3.971E-06 | 5.008E-03 | CA12, CA7, CA9 |
MF | GO:0003824; catalytic activity | GO:0034875; caffeine oxidase activity | 4.370E-06 | 5.008E-03 | CYP1A2, CYP3A4 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 7.333E-06 | 7.604E-03 | CA12, CA7, CA9 |
MF | GO:0003824; catalytic activity | GO:0016903; oxidoreductase activity, acting on the aldehyde or oxo group of donors | 7.333E-06 | 7.604E-03 | AKR1B1, AKR1B10, ALDH1A1 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 7.853E-06 | 7.773E-03 | CYP1A2, CYP2D6, CYP3A4 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 3.443E-07 | 2.479E-05 | CA12, CA7, CA9 |
09160 Human Diseases | 09167 Infectious diseases | hsa05134 | Legionellosis | 1.302E-05 | 3.980E-04 | CASP7, CASP1, NFKB1 |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 2.157E-05 | 3.980E-04 | CYP1A2, ALDH1A1, CYP3A4 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 2.581E-05 | 3.980E-04 | CYP2D6, CYP1A2, CYP3A4 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 3.058E-05 | 3.980E-04 | CYP2D6, CYP1A2, CYP3A4 |
09160 Human Diseases | 09167 Infectious diseases | hsa05133 | Pertussis | 3.316E-05 | 3.980E-04 | CASP7, CASP1, NFKB1 |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 3.819E-04 | 2.500E-03 | AKR1B10, CYP1A2, ALDH1A1, AKR1B1, CYP3A4, HSD17B10 |
09160 Human Diseases | 09163 Neurodegenerative diseases | hsa05010 | Alzheimer's disease | 3.631E-04 | 2.500E-03 | CASP7, MAPT, HSD17B10 |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 2.724E-04 | 2.500E-03 | CYP1A2, CYP3A4 |
09100 Metabolism | 09101 Carbohydrate metabolism | hsa00052 | Galactose metabolism | 2.917E-04 | 2.500E-03 | AKR1B10, AKR1B1 |
09100 Metabolism | 09101 Carbohydrate metabolism | hsa00040 | Pentose and glucuronate interconversions | 4.212E-04 | 2.527E-03 | AKR1B10, AKR1B1 |
09100 Metabolism | 09103 Lipid metabolism | hsa00561 | Glycerolipid metabolism | 1.131E-03 | 5.428E-03 | AKR1B10, AKR1B1 |
09100 Metabolism | 09101 Carbohydrate metabolism | hsa00051 | Fructose and mannose metabolism | 3.323E-04 | 2.500E-03 | AKR1B10, AKR1B1 |
09150 Organismal Systems | 09151 Immune system | hsa04621 | NOD-like receptor signaling pathway | 1.056E-03 | 5.428E-03 | CASP1, NFKB1 |
09100 Metabolism | 09103 Lipid metabolism | hsa00140 | Steroid hormone biosynthesis | 1.093E-03 | 5.428E-03 | CYP1A2, CYP3A4 |
09150 Organismal Systems | 09154 Digestive system | hsa04976 | Bile secretion | 1.633E-03 | 6.915E-03 | NR1H4, CYP3A4 |
09150 Organismal Systems | 09151 Immune system | hsa04623 | Cytosolic DNA-sensing pathway | 1.329E-03 | 5.981E-03 | CASP1, NFKB1 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 2.170E-03 | 8.680E-03 | CYP1A2, CYP3A4 |
09160 Human Diseases | 09167 Infectious diseases | hsa05132 | Salmonella infection | 2.383E-03 | 9.032E-03 | CASP1, NFKB1 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
C00-D49: Neoplasms | Renal cancer | C64 | CA9; |
G00-G99: Diseases of the nervous system G00-G99 | Central nervous system disease | G00-G99 | MAPT; |
C00-D49: Neoplasms | Clear cell renal cell carcinoma | C64 | CA9; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Cognitive disorders | F01-F07, F04, F05, R41.3 | MAPT; |
C00-D49: Neoplasms | Lymphoma | C81-C86 | CA9; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | CA9; |
G00-G99: Diseases of the nervous system G00-G99 | Alzheimer disease | G30 | MAPT; |
G00-G99: Diseases of the nervous system G00-G99 | Neurodegenerative disease | G30-G32 | MAPT; |
C00-D49: Neoplasms | Cancer | C00-C96 | CA9; |
C00-D49: Neoplasms | Breast cancer | C50 | CA9; |